Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database

被引:0
作者
Yadong Wang
Jichang Liu
Cuicui Huang
Yukai Zeng
Yong Liu
Jiajun Du
机构
[1] Shandong University,Institute of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine
[2] Shandong University,Department of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine
来源
BMC Cancer | / 21卷
关键词
Lung cancer; Pulmonary invasive mucinous adenocarcinoma; Nomogram; SEER; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 125 条
[1]  
Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30
[2]  
Miller KD(2019)Proportion of lung adenocarcinoma in female never-smokers has increased dramatically over the past 28 years J Thorac Dis 11 2685-2688
[3]  
Jemal A(2015)The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification J Thorac Oncol 10 1243-1260
[4]  
Huang C(2018)Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study J Thorac Dis 10 3595-3608
[5]  
Qu X(2011)International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary Proc Am Thorac Soc 8 381-385
[6]  
Du J(2017)Pros: the present classification of mucinous adenocarcinomas of the lung Transl Lung Cancer Res 6 230-233
[7]  
Travis WD(2011)Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 24 653-664
[8]  
Brambilla E(2010)Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib Lung Cancer 68 185-191
[9]  
Nicholson AG(2016)Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas J Thorac Oncol 11 1064-1073
[10]  
Yatabe Y(2013)Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients J Thorac Oncol 8 52-61